Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages

  Papini, Enrico ^a   Bizzarri, Giancarlo ^a   Bianchini, Antonio ^a   Valle, Dario ^a   Misischi, Irene ^a   Guglielmi, Rinaldo ^a   Salvatori, Massimo ^b   Solbiati, Luigi ^c   Crescenzi, Anna ^a   Pacella, Claudio Maurizio ^a   Gharib, Hossein ^d  

^a REGINA APOSTOLORUM HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c BUSTO ARSIZIO HOSPITAL   (Italy)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PROTHROMBIN; RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD CELL COUNT; CANCER CONTROL; CANCER GROWTH; CANCER RECURRENCE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG UPTAKE; DYSPHONIA; FEMALE; FOLLOW UP; HUMAN; LASER SURGERY; LIOTHYRONINE BLOOD LEVEL; LYMPH NODE METASTASIS; MALE; NECK DISSECTION; PAIN THRESHOLD; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TUMOR SEEDING; TUMOR VOLUME; ULTRASOUND SURGERY;

ADULT; AGED; CARCINOMA; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; SURGERY, COMPUTER-ASSISTED; THYROID NEOPLASMS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 84872089949     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2991     Document Type: Article

References (19)

1. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
2. Burman KD 2012 Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options. J Clin Endocrinol Metab 97:2623-2625
3. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90-96
4. Lewis BD, Hay ID, Charboneau JW, Charbonau JW, Mclever B, Reading CC, Goellner JR 2002 Percutaneous ethanol injection for the treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. Am J Roentgenol 178:699-704
5. Monchick JM, Donatini G, Iannocilli J, Dupuy E 2006 Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Am J Surg 244:296-304
6. Heilo A, Sigstad E, Fagerlid KH, Håskjold OI, Grøholt KK, Berner A, Bjøro T, Jørgensen LH 2011 Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab 96:2750-2755
7. Dupuy DE, Monchik JM, Decrea C, Pisharodi L 2001 Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130:971-977
8. Park KW, Shin JH, Han BK, Ko EY, Chung JH 2011 Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol 18:2564-2568
9. Baek JH, Kim YS, Sung JY, Choi H, Lee JH 2011 Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am J Roentgenol 197:W331-W336
10. Pacella CM, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A, Pacella S, Papini E 2000 Thyroid tissue: US-guided percutaneous interstitial laser ablation: a feasibility study. Radiology 217:673-677
11. Døssing H, Bennedbæk FN, Hegedüs L 2011 Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol 165:123-128
12. Papini E, Guglielmi R, Bizzarri G, Pacella CM 2004 Ultrasound-guided laser thermal ablation of benign thyroid nodules. Endocr Pract 10:276-283
13. Pacella CM, Bizzarri G, Spiezia S, Bianchini A, Guglielmi R, Crescenzi A, Pacella S, Toscano V, Papini E 2004 Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 232:272-280
14. Papini E, Bizzarri G, Pacella CM 2008 Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obes 15:434-439
15. Cakir B, Topaloglu O, Gul K, Agac T, Aydin C, Dirikoc A, Ersoy RU, Gumus M, Yazicioglu K, Yalcin B, Demirkazik A, Icli F, Ceyhan K 2007 Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: the introduction of a novel alternative palliative therapy-second experience in the literature. J Endocrinol Invest 30:624-625
16. Papini E, Guglielmi R, Gharib H, Hosseim G, Misischi I, Graziano F, Chianelli M, Crescenzi A, Bianchini A, Valle D, Bizzarri G 2011 Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid 21:917-920
17. Pfister DG, Fagin JA 2008 Refractory thyroid cancer: a paradigm shift in the treatment is not far off. J Clin Oncol 26:4701-4704
18. Robenshtok E, Fish S, Bach A, Domínguez JM, Shaha A, Tuttle RM 2012 Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab 97:2706-2713
19. Shaha AR 2012 Recurrent differentiated thyroid cancer. Endocr Pract 18:600-703